ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Beyond just promise, CRISPR is delivering in the lab today – The Conversation US

Continue reading

2017-05-18 Michael Zand NEWS

Gene therapy, microbubbles and ultrasound help heal broken bones – Cosmos

CosmosGene therapy, microbubbles and ultrasound help heal broken bonesCosmosThe new method patches the break with a collagen scaffold for bone progenitor cells to grow in, then injects microbubbles mixed with genetic material that produces a bone growt… Continue reading

2017-05-18 Michael Zand NEWS

Merck, Incyte immunotherapy combination effective in lung cancer study – Nasdaq

NasdaqMerck, Incyte immunotherapy combination effective in lung cancer studyNasdaq(Adds share move, links to stories on other ASCO research released) By Bill BerkrotMay 17 (Reuters) – A combination of the Merck & Co <MRK.N> immunotherapy Keyt… Continue reading

2017-05-17 Michael Zand NEWS

Bluebird, Kite and Juno Delivering CAR-T Cancer Study Updates to ASCO ’17 Meeting – TheStreet.com


The Conversation US

Beyond just promise, CRISPR is delivering in the lab today
The Conversation US
Researchers are starting to harness the potential of this much-hyped gene editing technique – with coming applications in medicine, biology and agriculture.

and more »

Continue reading

2017-05-17 Michael Zand NEWS

Merck, Incyte immunotherapy combination effective in lung cancer study – Reuters

Business WireMerck, Incyte immunotherapy combination effective in lung cancer studyReutersA combination of the Merck & Co immunotherapy Keytruda and a different type of drug that also helps the immune system fight cancer from Incyte Corp led to a h… Continue reading

2017-05-17 Michael Zand NEWS

Kite Announces Presentations on Its Lead CAR-T Therapy Development Program at the 2017 American Society of … – Business Wire (press release)

Bluebird, Kite and Juno Delivering CAR–T Cancer Study Updates to ASCO ’17 Meeting
TheStreet.com
The drug companies engineering T–cells to recognize and kill cancer, otherwise known as chimeric antigen receptor T–cells, or CAR-Ts, will be busy at the American Society of Clinical Oncology (ASCO) annual meeting in June. Investors, however, won’t …
Broad Range of Clinical Data Evaluating Celgene Therapies to Be Presented at American Society of Clinical Oncology …Business Wire (press release)

all 9 news articles »

Continue reading

2017-05-17 Michael Zand NEWS

Incyte Shares Jump After ‘IDO’ Cancer Immunotherapy Combo Data Revealed – TheStreet.com

Kite Announces Presentations on Its Lead CAR–T Therapy Development Program at the 2017 American Society of …
Business Wire (press release)
Kite’s lead product candidate, axicabtagene ciloleucel, previously known as KTE-C19, is an investigational therapy in which a patient’s T cells are engineered to express a chimeric antigen receptor (CAR) to target the antigen CD19, a protein expressed …

and more »

Continue reading

2017-05-17 Michael Zand NEWS

Scientists get closer to making personalized blood cells by using patients’ own stem cells – Los Angeles Times

Incyte Shares Jump After ‘IDO’ Cancer Immunotherapy Combo Data Revealed
TheStreet.com
Never-before-seen data from mid-stage clinical trials combining Incyte’s (INCY) IDO inhibitor epacadostat with Keytruda and Opdivo, the anti-PD-1 checkpoint inhibitors marketed by Merck (MRK) and Bristol-Myers Squibb (BMY) , respectively, have been …

Continue reading

2017-05-17 Michael Zand NEWS
  • 1
  • …
  • 1,713
  • 1,714
  • 1,715
  • 1,716
  • 1,717
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Los Angeles Times

Scientists get closer to making personalized blood cells by using patients’ own stem cells
Los Angeles Times
New research has nudged scientists closer to one of regenerative medicine’s holy grails: the ability to create customized human stem cells capable of forming blood that would be safe for patients. Advances reported Wednesday in the journal Nature could …
Lab-grown blood stem cells produced at lastNature.com
Blood Stem Cells Grown in the LabThe Scientist
Is this the end of blood donation?Scientists close to unlimited supply from stem cellsTelegraph.co.uk
New Scientist –Science Daily –The Australian
all 16 news articles »